Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
World Journal of Surgery
Erschienen in: World Journal of Surgery 8/2013

01.08.2013

Extended Lymphadenectomy in Rectal Cancer Is Debatable

verfasst von: Marco E. Allaix, Alessandro Fichera

Erschienen in: World Journal of Surgery | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Because of the major improvements in local control and survival with neoadjuvant combined modality therapy and total mesorectal excision, extended lymph node dissection plays a very limited role in rectal cancer surgery.
Literatur
1.
André T, Boni C, Navarro M et al (2009) Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27:3109–3116PubMedCrossRef
2.
Chang GJ, Rodriguez-Bigas MA, Skibber JM et al (2007) Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 99:433–441PubMedCrossRef
3.
NICE Improving Outcomes in Colorectal Cancer (2004) Manual update. National Institute for Clinical Excellence, London
4.
Nelson H, Petrelli N, Carlin A, National Cancer Institute Expert Panel (2001) Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 93:583–596PubMedCrossRef
5.
Goldstein NS, Sanford W, Coffey M et al (1996) Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol 106:209–216PubMed
6.
Hernanz F, Revuelta S, Redondo C et al (1994) Colorectal adenocarcinoma: quality of the assessment of lymph node metastases. Dis Colon Rectum 37:373–376PubMedCrossRef
7.
Wong JH, Severino R, Honnebier MB et al (1999) Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 17:2896–2900PubMed
8.
Evans MD, Barton K, Rees A et al (2008) The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes’ stage B disease. Colorectal Dis 10:157–164PubMed
9.
Sermier A, Gervaz P, Egger JF et al (2006) Lymph node retrieval in abdominoperineal surgical specimen is radiation time-dependent. World J Surg Oncol 4:29PubMedCrossRef
10.
Wichmann MW, Muller C, Meyer G et al (2002) Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer. Arch Surg 137:206–210PubMedCrossRef
11.
Baxter NN, Morris AM, Rothenberger DA et al (2005) Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis. Int J Radiat Oncol Biol Phys 61:426–431PubMedCrossRef
12.
Nagtegaal ID, van de Velde CJ, van der Worp E et al (2002) Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 20:1729–1734PubMedCrossRef
13.
Rullier A, Laurent C, Capdepont M et al (2008) Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival. Am J Surg Pathol 32:45–50PubMedCrossRef
14.
Joseph NE, Sigurdson ER, Hanlon AL et al (2003) Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol 10:213–218PubMedCrossRef
15.
Jakub JW, Russell G, Tillman CL et al (2009) Colon cancer and low lymph node count. Who is to blame? Arch Surg 144:1115–1120PubMedCrossRef
16.
Baxter NN, Virnig DJ, Rothenberger DA et al (2005) Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst 97:219–225PubMedCrossRef
17.
Gelos M, Gelhaus J, Mehnert P et al (2008) Factors influencing lymph node harvest in colorectal surgery. Int J Colorectal Dis 23:53–59PubMedCrossRef
18.
Tepper JE, O’Connell MJ, Niedzwiecki D et al (2001) Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 19:157–163PubMed
19.
MacFarlane JK, Ryall RDH, Heald RJ (1993) Mesorectal excision for rectal cancer. Lancet 1993(341):457–460CrossRef
20.
Heald RJ, Moran BJ, Ryall RDH et al (1998) The Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg 133:894–899PubMedCrossRef
21.
Fujita S, Yamamoto S, Akasu T et al (2003) Lateral pelvic lymph node dissection for advanced lower rectal cancer. Br J Surg 90:1580–1585PubMedCrossRef
22.
Ueno M, Oya M, Azekura K et al (2005) Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br J Surg 92:756–763PubMedCrossRef
23.
Sugihara K, Kobayashi H, Kato T et al (2006) Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 49:1663–1672PubMedCrossRef
24.
Mori T, Takahashi K, Yasuno M (1998) Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: the impact of lateral lymph node dissection. Langenbecks Arch Surg 383:409–415PubMedCrossRef
25.
Valentini V, Aristei C, Glimelius B et al (2009) Multidisciplinary rectal cancer management: 2nd European Rectal Cancer Consensus Conference (EURECAcc2). Radiother Oncol 92:148–163PubMedCrossRef
26.
Japanese Society for Cancer of the Colon and Rectum (2009) Japanese classification of colorectal carcinoma, 2nd English edn. Kanehara & Co., Tokyo
27.
Steup WH (1994) Chapter 6: historical comparison Japanese data NCCH; comparison between Japan and the Netherlands. Doctoral thesis, Colorectal cancer surgery with emphasis on lymphadenectomy. ISBN: 90-9007890-8. 1994;83–100
28.
29.
Kim TH, Jeong SY, Choi DH et al (2008) Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 15:729–737PubMedCrossRef
30.
Syk E, Torkzad MR, Blomqvist L et al (2006) Radiological findings do not support lateral residual tumour as a major cause of local recurrence of rectal cancer. Br J Surg 93:113–119PubMedCrossRef
31.
Kusters M, Beets GL, van de Velde CJH et al (2009) A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence. Ann Surg 249:229–235PubMedCrossRef
32.
Georgiou P, Tan E, Gouvas N et al (2009) Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol 10:1053–1062PubMedCrossRef
33.
Yano H, Moran BJ, Watanabe T et al (2010) Lateral pelvic lymph-node dissection: still an option for cure. Lancet Oncol 11:114; author reply 114–115
34.
Nagawa H, Muto T, Sunouchi K et al (2001) Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 44:1274–1280PubMedCrossRef
35.
Watanabe T, Tsurita G, Muto T et al (2002) Extended lymphadenectomy and preoperative radiotherapy for lower rectal cancers. Surgery 132:27–33PubMedCrossRef
36.
Dharmarajan S, Shuai D, Fajardo AD et al (2011) Clinically enlarged lateral pelvic lymph nodes do not influence prognosis after neoadjuvant therapy and TME in stage III rectal cancer. J Gastrointest Surg 15:1368–1374PubMedCrossRef
37.
Fujita S, Akasu T, Mizusawa J et al (2012) Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicenter, randomized controlled, non-inferiority trial. Lancet Oncol 13:616–621PubMedCrossRef
38.
Kyo K, Sameshima S, Takahashi M et al (2006) Impact of autonomic nerve preservation and lateral node dissection on male urogenital function after total mesorectal excision for lower rectal cancer. World J Surg 30:1014–1019. doi:10.​1007/​s00268-005-0050-9 PubMedCrossRef
39.
Lange MM, Maas CP, Marijnen CA et al (2008) Urinary dysfunction after rectal cancer treatment is mainly caused by surgery. Br J Surg 95:1020–1028PubMedCrossRef
40.
Lange MM, Marijnen CA, Maas CP et al (2009) Risk factors for sexual dysfunction after rectal cancer treatment. Eur J Cancer 45:1578–1588PubMedCrossRef
41.
Moynihan BG (1908) The surgical treatment of cancer of the sigmoid flexure and rectum. Surg Gynecol Obstet 6:463–466
42.
Nelson H, Petrelli N, Carlin A et al (2001) Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 93:583–596PubMedCrossRef
43.
Edge SB, Byrd DR, Compton CC et al (eds) (2010) AJCC cancer staging manual, 7th edn. Springer, New York
44.
Kanemitsu Y, Hirai T, Komori K et al (2006) Survival benefit of high ligation of the inferior mesenteric artery in sigmoid colon or rectal cancer surgery. Br J Surg 93:609–615PubMedCrossRef
45.
Yi JW, Lee TG, Lee HS et al (2012) Apical-node metastasis in sigmoid colon or rectal cancer: is it a factor that indicates a poor prognosis after high ligation? Int J Colorectal Dis 27:81–87PubMedCrossRef
46.
Kang J, Hur H, Min BS et al (2011) Prognostic impact of inferior mesenteric artery lymph node metastasis in colorectal cancer. Ann Surg Oncol 18:704–710PubMedCrossRef
47.
Lange MM, Buunen M, van de Velde CJH et al (2008) Level of arterial ligation in rectal cancer surgery: low tie preferred over high tie. A review. Dis Colon Rectum 51:1139–1145PubMedCrossRef
48.
Titu LV, Tweedle E, Rooney PS (2008) High tie of the inferior mesenteric artery in curative surgery for left colonic and rectal cancers: a systematic review. Dig Surg 25:148–157PubMedCrossRef
49.
Cirocchi R, Trastulli S, Farinella E et al (2012) High tie versus low tie of the inferior mesenteric artery in colorectal cancer: a RCT is needed. Surg Oncol 21:e111–e123PubMedCrossRef
50.
Slanetz CA Jr, Grimson R (1997) Effect of high and intermediate ligation on survival and recurrence rates following curative resection of colorectal cancer. Dis Colon Rectum 40:1205–1218PubMedCrossRef
51.
Pezim ME, Nicholls RJ (1984) Survival after high or low ligation of the inferior mesenteric artery during curative surgery for rectal cancer. Ann Surg 200:729–733PubMedCrossRef
52.
Chin CC, Yeh CY, Tang R et al (2008) The oncologic benefit of high ligation of the inferior mesenteric artery in the surgical treatment of rectal or sigmoid colon cancer. Int J Colorectal Dis 23:783–788PubMedCrossRef
53.
Huh JW, Kim YJ, Kim HR (2012) Distribution of lymph node metastases is an independent predictor of survival for sigmoid colon and rectal cancer. Ann Surg 255:70–78PubMedCrossRef
54.
Meyers MA (1976) Griffiths’ point: critical anastomosis at the splenic flexure. Significance in ischemia of the colon. AJR Am J Roentgenol 126:77–94PubMedCrossRef
55.
Dworkin MJ, Allen-Mersh TG (1996) Effect of inferior mesenteric artery ligation on blood flow in the marginal artery-dependent sigmoid colon. J Am Coll Surg 183:357–360PubMed
56.
Seike K, Koda K, Saito N et al (2007) Laser Doppler assessment of the influence of divison at the root of the inferior mesenteric artery on anastomotic blood flow in rectosigmoid cancer surgery. Int J Colorectal Dis 22:689–697PubMedCrossRef
57.
Vignali A, Gianotti L, Braga M et al (2000) Altered microperfusion at the rectal stump is predictive for rectal anastomotic leak. Dis Colon Rectum 43:76–82PubMedCrossRef
58.
http://www.websurg.com/MEDIA/?noheader¼1&doi¼ot02en202. Accessed 4 April 2012
59.
Corcione F, Miranda L, Settembre A (2008) La chirurgia laparoscopica del retto: total mesorectal excision. In: Corcione F, Miranda L, Ruotolo G (eds) Chirurgia laparoscopica. Idelson-Gnocchi, Reddick, pp 293–305
60.
Rullier E (2005) Exérèse laparoscopique des cancers du rectum. In: Valleur P (ed) Chirurgie du tube digestif bas. Masson, Paris, pp 143–150
61.
Buunen M, Lange MM, Ditzel M et al (2009) Level of arterial ligation in total mesorectal excision (TME): an anatomical study. Int J Colorectal Dis 24:1317–1320PubMedCrossRef
62.
Bonnet S, Berger A, Hentati N et al (2012) High tie versus low tie vascular ligation of the inferior mesenteric artery in colorectal cancer surgery: impact on the gain in colon length and implications on the feasibility of anastomoses. Dis Colon Rectum 55:515–521PubMedCrossRef
63.
Grinnell RS (1965) Results of ligation of inferior mesenteric artery at the aorta in resections of carcinoma of the descending and sigmoid colon and rectum. Surg Gynecol Obstet 120:1031–1036PubMed
64.
Adachi Y, Inomata M, Miyazaki N et al (1998) Distribution of lymph node metastasis and level of inferior mesenteric artery ligation in colorectal cancer. J Clin Gastroenterol 26:179–182PubMedCrossRef
65.
Rutegård M, Hemmingsson O, Matthiessen P et al (2012) High tie in anterior resection for rectal cancer confers no increased risk of anastomotic leakage. Br J Surg 99:127–132PubMedCrossRef
66.
Trencheva K, Morrissey KP, Wells M et al (2013) Identifying important predictors for anastomotic leak after colon and rectal resection: prospective study on 616 patients. Ann Surg 257:108–113PubMedCrossRef
67.
Sato K, Inomata M, Kakisako K et al (2003) Surgical technique influences bowel function after low anterior resection and sigmoid colectomy. Hepatogastroenterology 50:1381–1384PubMed
68.
Liang JT, Huang KC, Lai HS et al (2007) Oncologic results of laparoscopic D3 lymphadenectomy for male sigmoid and upper rectal cancer with clinically positive lymph nodes. Ann Surg Oncol 14:1980–1990PubMedCrossRef
69.
Nano M, Dal Corso H, Ferronato M et al (2004) Ligation of the inferior mesenteric artery in the surgery of rectal cancer: anatomical considerations. Dig Surg 21:123–127PubMedCrossRef
Metadaten
Titel
Extended Lymphadenectomy in Rectal Cancer Is Debatable
verfasst von
Marco E. Allaix
Alessandro Fichera
Publikationsdatum
01.08.2013
Verlag
Springer US
Erschienen in
World Journal of Surgery / Ausgabe 8/2013
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-013-2030-9

Weitere Artikel der Ausgabe 8/2013

World Journal of Surgery 8/2013 Zur Ausgabe

OriginalPaper

Patient Attitudes toward Transaxillary Robot-assisted Thyroidectomy

OriginalPaper

Long-Term Outcome and Quality of Life After Laparoscopic Treatment of Large Paraesophageal Hernia

OriginalPaper

Extended Lymphadenectomy in Pancreatic Cancer Is Crucial

OriginalPaper

Contemporary Management of Adult Intussusception: Who Needs a Resection?

OriginalPaper

Occurrence and Significance of Odontoid Lateral Mass Interspace Asymmetry in Trauma Patients

ReviewPaper

Prophylactic Mesh Placement in High-Risk Patients Undergoing Elective Laparotomy: A Systematic Review

Neu im Fachgebiet Chirurgie

17.04.2024 | Postoperative nausea and vomiting | Nachrichten

Hochrisiko-Eingriffe für postoperative Übelkeit

16.04.2024 | Infektiologie | Nachrichten

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

10.04.2024 | Postoperative Schmerztherapie | Nachrichten

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente

10.04.2024 | Narbenhernie | Nachrichten

Deutlich weniger Narbenhernien mit der Small-Bites-Technik
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom CME-Kurs
CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur CME-Kurs
CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis CME-Kurs
CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.